As on Thursday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) started slowly as it slid -7.43% to $9.6, before settling in for the price of $10.37 at the close. Taking a more long-term approach, OLMA posted a 52-week range of $2.86-$13.51.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -83.00%. Meanwhile, its Annual Earning per share during the time was -83.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 14.29%. This publicly-traded company’s shares outstanding now amounts to $68.63 million, simultaneously with a float of $52.86 million. The organization now has a market capitalization sitting at $658.89 million. At the time of writing, stock’s 50-day Moving Average stood at $7.77, while the 200-day Moving Average is $5.51.
Olema Pharmaceuticals Inc (OLMA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Olema Pharmaceuticals Inc’s current insider ownership accounts for 22.99%, in contrast to 85.68% institutional ownership. According to the most recent insider trade that took place on Sep 18 ’25, this organization’s Director sold 10,000 shares at the rate of 8.33, making the entire transaction reach 83,300 in total value, affecting insider ownership by 744,140. Preceding that transaction, on Sep 16 ’25, Company’s Director sold 10,000 for 8.04, making the whole transaction’s value amount to 80,400. This particular insider is now the holder of 754,140 in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.48 per share during the current fiscal year.
Olema Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 14.29% and is forecasted to reach -2.17 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 0.90% through the next 5 years, which can be compared against the -83.00% growth it accomplished over the previous five years trading on the market.
In the same vein, OLMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.92, a figure that is expected to reach -0.47 in the next quarter, and analysts are predicting that it will be -2.17 at the market close of one year from today.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Through scrutinizing the latest numbers posted by the [Olema Pharmaceuticals Inc, OLMA], it can be observed that its last 5-days Average volume of 1.34 million was better the volume of 0.94 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 22.05% While, its Average True Range was 42.35.
Raw Stochastic average of Olema Pharmaceuticals Inc (OLMA) in the period of the previous 100 days is set at 74.60%, which indicates a major rise in contrast to 14.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.79 that was higher than 0.47 volatility it exhibited in the past 100-days period.
